The Mark Foundation for Cancer Research (US) Ltd logo

The Mark Foundation for Cancer Research (US) Ltd

Public charity · Grantmaker New York, NY EIN: 36-4825921 Website

The Mark Foundation for Cancer Research is a New York, New York-based public charity, formed in 2015. It supports cancer research through grants and venture investments, partnering with individual investigators, multidisciplinary teams, and early-stage companies in the United States and internationally.

The Mark Foundation for Cancer Research (US) Ltd at a glance

In short: The Mark Foundation for Cancer Research (US) Ltd gave $19.5M across 29 grants in 2024 (avg $672K), top state New York. 17% of 2024 grantees were new. Source: 2024 IRS Form 990.

Annual giving (2024)
$19,485,041
-20.2% vs 2023
Grants made (2024)
29
-19.4% vs 2023
Average grant
$671,898
-0.9% vs 2023
Median grant
$500,000
Total assets
$105,459,714
+0.9% vs 2023
New grantees (estimate)
17% first-time grantees (5 of 29, 2024)
Primary geography
New York (32% of itemized 2024 grant dollars)
Latest 990 filing
Form 990, 2024 View filing

Data from IRS Form 990, 2024; updated September 2026. New grantees are estimated by matching recipient names across years (methodology).

How to apply to The Mark Foundation for Cancer Research (US) Ltd

Contact

Mailing address: 1350 Avenue Of The Americas 2902, New York, NY 10019
Phone: (646) 866-5950
Website: https://themarkfoundation.org

Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.

Who The Mark Foundation for Cancer Research (US) Ltd funds

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

The Trustees of Columbia University in the City of New York: $2.8MThe Trustees of ColumbiaUniversity in the City of New…$2.8MRegents of the University of California San Francisco: $2.3MRegents of the University ofCalifornia San Francisco$2.3MMemorial Sloan Kettering Cancer Center: $1.6MMemorial Sloan KetteringCancer Center$1.6MJohns Hopkins University: $1.4MJohns Hopkins University$1.4MThe Salk Institute for Biological Studies: $1.0MThe Salk Institute forBiological Studies$1.0MUniversity of Alabama at Birmingham: $1.0MUniversity of Alabama atBirmingham$1.0MUniversity of Pittsburgh - of the Commonwealth System of Higher Education: $1.0MUniversity of Pittsburgh - ofthe Commonwealth System of…$1.0MThe Board of Trustees of the Leland Stanford Junior University: $948KThe Board of Trustees of theLeland Stanford Junior…$948KCold Spring Harbor Laboratory: $750KCold Spring Harbor Laboratory$750KPresident and Fellows of Harvard College: $711KPresident and Fellows ofHarvard College$711K

The largest 2024 recipient was The Trustees of Columbia University in the City of New York ($2.8M). Together the top 10 received $13.4M.

Grant Size Distribution

165 grants across all recorded years

9<$50K17$50–100K28$100–250K36$250–500K37$500K–1M38$1–5M$5M+

The most common grant size was in the $1–5M range: 38 grants of 165 (23%).

Geographic Focus

Where this funder awards grants

The foundation states that it supports research in the United States and across the globe. Its 2024 grant dollars were distributed among recipients in New York (32%), California (27%), Massachusetts (9%), Maryland (7%), and Alabama (5%), among other states.

Grant Distribution by State

27states

Share of 2024 grant dollars across all 29 itemized grants.

Cities

New YorkBostonBaltimoreSeattleHoustonCambridgePhiladelphiaSan FranciscoBar HarborBerkeleyColumbusCold Spring HarborNew HavenPittsburghPortlandRedwood CityRye BrookWashingtonWashington DCAnn Arbor

Is The Mark Foundation for Cancer Research (US) Ltd open to new grantees?

17%

first-time grantees, 2024

In 2024, 5 of 29 grantees (17%) were first-time recipients. First grants averaged $815K; repeat grants $642K. How we count

Medians: $250K first-time, $535K repeat.

  • 45% of 2024 grantees were also funded in 2023. Method
  • Giving fell 22% from 2021 to 2024. Method

Estimate from itemized grant lists in IRS Form 990 filings (2019–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.

Giving History

Giving Over Time

Total grant dollars and number of grants per year

$0$20M$40M$60M27 grants2019 28 grants2020 36 grants2021 36 grants2022 36 grants2023 29 grants2024

From 2019 to 2024, annual grant giving ranged from $16.4M (2020) to $42.3M (2019). In 2024 it made 29 grants totaling $19.5M.

Grants by year

Grant recipients and amounts by year

RecipientPurposeAmount
The Trustees of Columbia University in the City of New York New York, NYResearch$2,750,000
Regents of the University of California San Francisco San Francisco, CAResearch$2,299,837
Memorial Sloan Kettering Cancer Center New York, NYResearch$1,568,007
Johns Hopkins University Baltimore, MDResearch$1,384,340
The Salk Institute for Biological Studies La Jolla, CAResearch$1,000,000
University of Alabama at Birmingham Birmingham, ALResearch$1,000,000
University of Pittsburgh - of the Commonwealth System of Higher Education Pittsburgh, PAResearch$1,000,000
The Board of Trustees of the Leland Stanford Junior University Redwood City, CAResearch$948,007
Cold Spring Harbor Laboratory Cold Spring Harbor, NYResearch$750,000
President and Fellows of Harvard College Cambridge, MAResearch$711,352
Your AI grants department

Ready to take the next step with The Mark Foundation for Cancer Research (US) Ltd?

Fully replaces Grant database subscriptions Instrumentl · Foundation Directory · GrantStation & similar

Financial History

Multi-year comparison from IRS filings

Figures from IRS filings, by filing year
Filing yearTotal AssetsRevenueExpensesGrants paidGrantsNet Investment Income
2024$105,459,714$44,772,901$36,066,750$19,485,04129$409,872
2023$104,492,388$40,937,632$35,209,497$24,414,17436$1,030,138
2022$110,652,350$55,345,494$38,014,606$22,043,84736$363,707
2021$107,551,757$37,486,883$35,686,709$25,019,23436$5,489,453
2020$109,005,993$40,176,299$21,645,747$16,366,71728$176,189
2019$90,919,630$80,534,924$47,346,929$42,269,01527$534,064

Research compiled by Grantable AI from public sources. Last updated September 2026.

Mission & Focus Areas

The foundation’s mission is to partner with scientists to accelerate research that can transform cancer prevention, diagnosis, and treatment. Its grants support innovative research across cancer types, including basic, translational, and clinical work, as well as collaborative projects and early-stage therapeutic discovery.

Its 2024 grants went to research institutions including universities, cancer centers, and independent research organizations. For example, Johns Hopkins University describes its mission as fostering independent and original research and bringing the benefits of discovery to the world. The Salk Institute says its work includes cancer research alongside other scientific fields. Harvard College describes its mission as education and research across a broad array of academic domains.

Grantmaking

In filing year 2024, the foundation reported 29 grants totaling $19,485,041. Grant amounts ranged from $11,250 to $2,750,000, with a median grant of $500,000. The largest awards included $2,750,000 to the Trustees of Columbia University in the City of New York, $2,299,837 to the Regents of the University of California San Francisco, $1,568,007 to Memorial Sloan Kettering Cancer Center, and $1,384,340 to Johns Hopkins University. Each was listed for research.

The foundation’s programs include ASPIRE Awards for high-impact, high-risk research, including projects with limited preliminary data; Drug Discovery Partnership awards to advance discoveries toward therapeutics; Emerging Leader Awards for early-career investigators; Endeavor Awards for collaborative teams; fellowships; and Mark Foundation Centers. Its website says submissions undergo rigorous peer review. The foundation also says it monitors grant progress, requires progress reports, and conditions further disbursements on acceptance of grant terms and timely reporting.

The Emerging Leader Award is listed as currently open, with a stated award range of $250,000–$1,000,000 and a deadline of April 30, 2026. Applicants must hold an MD, PhD, or equivalent degree, have established an independent laboratory during 2018–2023, and demonstrate multi-year independent funding active in 2027. The program is open to applicants worldwide; proposed projects must be based on evidence-based laboratory data and/or medical science and must not be supported by other sources.

The Endeavor Award is listed as currently open and provides up to $3 million over three years. It supports teams of one principal investigator and two to eight co-principal investigators at nonprofit academic or research institutions. Basic, translational, and clinical projects are eligible; investigators may be based anywhere, and projects should address an urgent scientific question with integrated team contributions. Proposed projects must not be supported by other sources.

ASPIRE supports independent researchers worldwide, with collaborations within scope. Proposals may be solicited through focused requests for proposals, or individual applications may be considered by invitation.

Leadership & Key People

Leadership team and compensation from IRS filings

The 2024 filing lists Raymond DuBois as executive chairman of the board and Ryan Schoenfeld as chief executive officer. It also lists Alex Knaster, Ross Levine, Nicola Mendehlson, Paul Pospisil, and Otmar D. Wiestler as directors; Ian Lesser as director of finance and administration; Anna Turetsky as principal, venture investments; and Rebecca Bish-Cornelissen as head of discovery/pre-clinical research.

The Mark Foundation for Cancer Research (US) Ltd is led by Ryan Schoenfeld, Chief Executive Officer since 2022 (on filings since 2019); 10 of 14 officers listed in 2024 are compensated.

Officers on the 2024 filing

  • Ryan Schoenfeld

    Chief Executive Officer

    Vice President & Scientific Research → Chief Scientific Officer & Interim CEO, 2021

    Chief Scientific Officer & Interim CEO → Chief Executive Officer, 2022

    On filings since 2019

    40 hrs/week

    $305K (2019) → $507K (2024)

  • Raymond Dubois

    Executive Chairman of the Board

    On filings since 2022

    24 hrs/week

    $513K (2022) → $560K (2024)

  • Rebecca Liu

    Director & Grants Administration

    Director of Grants Adminstration → Director of Grants Administration, 2022

    Director of Grants Administration → Director & Grants Administration, 2023

    On filings since 2019

    40 hrs/week

    $127K (2019) → $197K (2024)

  • Ross Levine

    Director

    On filings since 2019

    1 hr/week

    $10K (2019) → $10K (2024)

  • Michael Carleton

    Senior Scientific Director

    On filings since 2020

    40 hrs/week

    $212K (2020) → $176K (2024)

  • Ian Lesser

    Director Finance & Administration

    On filings since 2023

    40 hrs/week

    $67K (2023) → $173K (2024)

  • Paul Pospisil

    Director

    On filings since 2020

    1 hr/week

    No compensation reported

  • Alex Knaster

    Director

    On filings since 2023

    1 hr/week

    No compensation reported

  • Nicola Mendehlson

    Director

    On filings since 2023

    1 hr/week

    No compensation reported

  • Otmar D. Wiestler

    Director

    On filings since 2023

    1 hr/week

    No compensation reported

  • Rebecca Bish-Cornelissen

    Head Discovery & Pre-Clinical Research

    Head of Pre-Clinical Research → Head Discovery & Preclinical Research, 2023

    Head Discovery & Preclinical Research → Head Discovery & Pre-Clinical Research, 2024

    On filings since 2020

    40 hrs/week

    $261K (2020) → $311K (2024)

  • Robert Magin

    Associate Scientific Director

    On filings since 2022

    40 hrs/week

    $127K (2022) → $169K (2024)

  • Amy Fehir

    Head of Development

    On filings since 2023

    40 hrs/week

    $107K (2023) → $216K (2024)

  • Anna Turetsky To

    Principal & Venture Investments

    New on the 2024 filing

    40 hrs/week

    $327K (2024)

Former officers (16)
  • Former: Anna Turetsky (2020–2023) — Principal & Venture Investments
  • Former: Janice Lin (2022–2023) — Portfolio Manager, Research & Investments
  • Former: Kevin O'Flaherty To (2023) — Director
  • Former: S. Patrick Lewis To (2023) — Head of Finance & Operations
  • Former: Stuart Thomson To (2023) — Director
  • Former: William Shapard To (2023) — Director
  • Former: Kevin O' Flaherty (2019–2022) — Director
  • Former: S. Patrick Lewis (2019–2022) — Head of Finance & Operations
  • Former: Stuart Thomson (2019–2022) — Director
  • Former: William Allen Shapard (2019–2022) — Director
  • Former: Irena Ivanovska (2021–2022) — Senior Scientific Research
  • Former: Michele Cleary Ph D. To (2021) — Chairman of the Board & CEO
  • Former: Kasandra Davis (2019–2020) — Project Manager
  • Former: Michele Cleary PhD (2019–2020) — Chairman of the Board & CEO
  • Former: Elisa Venturini (2020) — Scientific Program Lead
  • Former: Rebecca Bish PhD (2019) — Senior Scientific Director

Data from IRS Form 990 filings, 2019–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.

Compensation Overview

From 2024 IRS filing

Raymond Dubois — Executive Chairman of the Board: $560KRaymond DuboisExecutive Chairman of the Board$560KRyan Schoenfeld — Chief Executive Officer: $507KRyan SchoenfeldChief Executive Officer$507KAnna Turetsky to 724 — Principal, Venture Investments: $327KAnna Turetsky to 724Principal, Venture Investments$327KRebecca Bish-Cornelissen — Head Discovery/Pre-Clinical Research: $311KRebecca Bish-CornelissenHead Discovery/Pre-Clinical…$311KAmy Fehir — Head of Development: $216KAmy FehirHead of Development$216KRebecca Liu — Director, Grants Administration: $197KRebecca LiuDirector, Grants Administration$197KMichael Carleton — Senior Scientific Director: $176KMichael CarletonSenior Scientific Director$176KIan Lesser — Director Finance & Administration: $173KIan LesserDirector Finance &…$173KRobert Magin — Associate Scientific Director: $169KRobert MaginAssociate Scientific Director$169KRoss Levine — Director: $10KRoss LevineDirector$10K

The highest reported compensation on the 2024 filing was $560K, to Raymond Dubois (Executive Chairman of the Board). 10 officers or directors reported compensation on that filing.

Frequently asked questions about The Mark Foundation for Cancer Research (US) Ltd

How much does The Mark Foundation for Cancer Research (US) Ltd give each year?

The Mark Foundation for Cancer Research (US) Ltd gave $19.5M across 29 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $24.4M across 36 grants.

What is The Mark Foundation for Cancer Research (US) Ltd's typical grant size?

The Mark Foundation for Cancer Research (US) Ltd's median grant in 2024 was $500,000, and its average grant was $671,898, across 29 grants on its 2024 IRS Form 990. Organizations receiving their first grant from The Mark Foundation for Cancer Research (US) Ltd that year got $815K on average.

Where does The Mark Foundation for Cancer Research (US) Ltd give grants?

The Mark Foundation for Cancer Research (US) Ltd's top state is New York, with 32% of the grant dollars itemized on its 2024 IRS Form 990. The next largest states were California (27%) and Massachusetts (9%). The most frequent recipient cities were New York, NY (6 grants) and Boston, MA (2 grants).

Does The Mark Foundation for Cancer Research (US) Ltd give general operating support?

Not in 2024: none of the 29 grants with a stated purpose on The Mark Foundation for Cancer Research (US) Ltd's 2024 IRS Form 990 were described as general or operating support. Recurring purposes include "Research" (29 grants).

Who are The Mark Foundation for Cancer Research (US) Ltd's largest grantees?

The Mark Foundation for Cancer Research (US) Ltd's largest 2024 grantees include The Trustees of Columbia University in the City of New York ($2,750,000), Regents of the University of California San Francisco ($2,299,837) and Memorial Sloan Kettering Cancer Center ($1,568,007), according to its 2024 IRS Form 990. Together they received 34% of its itemized 2024 grant dollars.

How large is The Mark Foundation for Cancer Research (US) Ltd?

The Mark Foundation for Cancer Research (US) Ltd reported $105.5M in total assets on its 2024 IRS Form 990. Its revenue that year was $44.8M.

What does The Mark Foundation for Cancer Research (US) Ltd fund?

The foundation’s mission is to partner with scientists to accelerate research that can transform cancer prevention, diagnosis, and treatment. See mission & focus areas ↑

How do I apply for a grant from The Mark Foundation for Cancer Research (US) Ltd?

The Mark Foundation for Cancer Research (US) Ltd has no public application process in the sources Grantable reviewed. Check themarkfoundation.org for current guidelines, or contact the foundation directly before submitting a request.

What is The Mark Foundation for Cancer Research (US) Ltd's EIN?

The Mark Foundation for Cancer Research (US) Ltd's EIN (Employer Identification Number) is 36-4825921. IRS Form 990 filing data is available on this page for 2019–2024.

Data last updated September 2026. Sourced from IRS Form 990 filings. Research dossier generated September 2026.

Data update history

(7)

When this profile's IRS filing data changed on Grantable

  1. Updated Form 990 for fiscal year 2019 (received by the IRS July 28, 2020)
  2. Added Form 990 for fiscal year 2020 (received by the IRS November 3, 2021)
  3. Updated Form 990 for fiscal year 2021 (received by the IRS September 1, 2022)
  4. Updated Form 990 for fiscal year 2022 (received by the IRS September 12, 2023)
  5. Updated Form 990 for fiscal year 2023 (received by the IRS September 13, 2024)
  6. Updated Form 990 for fiscal year 2024 (received by the IRS October 7, 2025)
  7. IRS filings on file for fiscal years 2019–2024

Live grants for the work The Mark Foundation for Cancer Research (US) Ltd funds

Diseases, Disorders & Medical Disciplines Open opportunities, soonest deadline first.

Explore Open Grants

Browse active grant opportunities in The Mark Foundation for Cancer Research (US) Ltd's focus areas in our free grants database

Similar Funders

Funders that support many of the same organizations

American Cancer Society Inc

Atlanta, GA

The American Cancer Society funds cancer research, patient support, and advocacy, including grants to researchers, institutions, and related organizations. Its 2025 grants ranged from $5,648 to $9.6 million, with a median of $15,000; research funding supports institutions across the United States. It accepts applications for specific research programs through ProposalCentral, but the profile does not state whether it accepts unsolicited requests generally.

Assets

$1.7B

Grants

509

Total Given

$23.1M

Emory University

Atlanta, GA

Emory University primarily funds research and subcontract work for universities, hospitals, research organizations, and other organizations, across a range of academic and health-related fields. Its 2025 grants ranged from $5,500 to $19.1 million, with a median of about $97,000; 41% of grant dollars went to Georgia recipients. The profile does not state whether Emory accepts unsolicited requests.

Assets

$24.9B

Grants

362

Total Given

$183.7M

Bristol-Myers Squibb Foundation Inc

Princeton, NJ

The Bristol-Myers Squibb Foundation supports health access and stronger health systems, with a focus on adult and pediatric cancers, blood disorders, brain health, and clinical-trial participation in the United States, Brazil, India, and ten Sub-Saharan African countries. In 2024, its median grant was about $134,000, though awards varied widely; it does not state whether it accepts unsolicited requests, and advises prospective applicants to contact the Foundation about its process.

Assets

$83.3M

Grants

144

Total Given

$67.7M

Yale University

New Haven, CT

Yale University funds sponsored research, education and institutional programs, student aid, and charitable or community support, with 2025 grants ranging from $3,000 to $14.3 million and a median of about $136,000. Grants went to recipients in multiple states, with the largest shares in Connecticut, California, Massachusetts, New York, and Pennsylvania. The information does not state whether Yale accepts unsolicited requests.

Education

Assets

$58.9B

Grants

364

Total Given

$168.2M

Silicon Valley Community Foundation

Mountain View, CA

Silicon Valley Community Foundation funds work in areas such as housing, economic security, education, health, the environment, arts and culture, and civic engagement, with Community Action Grants supporting local, community-led organizations in San Mateo and Santa Clara counties. Its 2024 grants had a median of $51,716, though amounts varied widely; applications depend on the program, and SVCF states that it does not accept unsolicited proposals for advised funds.

Philanthropy, Voluntarism & Grantmaking

Assets

$12.3B

Grants

3,576

Total Given

$3.2B

The Trustees of Columbia University in the City of New York

New York, NY

Columbia funds research, education and research, and capital projects, primarily through grants to universities and medical and research institutions across the United States, with the largest share going to New York recipients. Its 2025 grants had a median of about $109,000, though awards ranged from $5,350 to $15.1 million. The profile does not state whether it accepts unsolicited requests.

Assets

$26.0B

Grants

417

Total Given

$208.3M

More similar funders

More Funders in New York

Cite this profile

Grantable. (2026). The Mark Foundation for Cancer Research (US) Ltd funder profile. GrantGraph. Retrieved October 22, 2026, from https://grantable.co/funders/the-mark-foundation-for-cancer-research-us-ltd-morg_4a0f66892b09461bba51b6d3ea1303f2

BibTeX
@misc{grantable_364825921_2026,
  author       = {{Grantable}},
  title        = {{The Mark Foundation for Cancer Research (US) Ltd funder profile}},
  howpublished = {GrantGraph},
  year         = {2026},
  url          = {https://grantable.co/funders/the-mark-foundation-for-cancer-research-us-ltd-morg_4a0f66892b09461bba51b6d3ea1303f2},
  note         = {Accessed 2026-10-22. Data licensed CC BY 4.0}
}

The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.

Figures come from The Mark Foundation for Cancer Research (US) Ltd's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.

The Mark Foundation for Cancer Research (US) Ltd down — hundreds of funders to go?

Want AI to do this for you?